
Isomorphic Labs, the AI-driven drug discovery startup founded by Demis Hassabis, has raised $5 billion in a Series C funding round to advance the development of new medicines using artificial intelligence.
The funding comes 3.5 months after Hassabis stepped back as CEO of Google DeepMind, the AI research lab he co-founded before Google acquired it in 2014.
The round was co-led by Greenoaks and Sequoia Capital, with participation from Andreessen Horowitz and Alphabet, Google’s parent company. The fresh capital will support the design and development of new medicines through AI.
Hassabis has continued to lead Isomorphic Labs since it was spun out of DeepMind in 2021. Commenting on the company’s vision, he said, “When we founded Isomorphic, our conviction was that biology could be understood and modelled at the most fundamental molecular level and radically accelerated through AI.”
He added, “This round enables us to accelerate our progress: building foundational biology models, deepening our systemic disease understanding, and driving our first therapeutic programs towards clinical trials to deliver tangible impact for patients.”
Isomorphic Labs is developing a proprietary drug design engine and a pipeline of AI-designed therapeutic candidates, with the aim of advancing the next generation of medicines.
The funding comes amid growing investor interest in AI-powered drug discovery. Startups in the sector have raised a record $23.2 billion in 2026, according to Dealroom. Companies such as OpenAI and Anthropic are also exploring the use of AI in medicine development. Anthropic launched an AI drug discovery programme in June, while OpenAI partnered with Novo Nordisk in April.
Isomorphic Labs previously raised $2.1 billion in a Series B round in May.
Also read: Viksit Workforce for a Viksit Bharat
Do Follow: The Mainstream LinkedIn | The Mainstream Facebook | The Mainstream Youtube | The Mainstream Twitter
About us:
The Mainstream is a premier platform delivering the latest updates and informed perspectives across the technology business and cyber landscape. Built on research-driven, thought leadership and original intellectual property, The Mainstream also curates summits & conferences that convene decision makers to explore how technology reshapes industries and leadership. With a growing presence in India and globally across the Middle East, Africa, ASEAN, the USA, the UK and Australia, The Mainstream carries a vision to bring the latest happenings and insights to 8.2 billion people and to place technology at the centre of conversation for leaders navigating the future.

